CD14+ cells are required for IL-12 response in bovine blood mononuclear cells activated with Toll-like receptor (TLR) 7 and TLR8 ligands.

[1]  M. Fuertes,et al.  Engagement of TLR3, TLR7, and NKG2D Regulate IFN-γ Secretion but Not NKG2D-Mediated Cytotoxicity by Human NK Cells Stimulated with Suboptimal Doses of IL-121 , 2007, The Journal of Immunology.

[2]  Shizuo Akira,et al.  Antiviral signaling through pattern recognition receptors. , 2006, Journal of biochemistry.

[3]  A. Moretta,et al.  Multi-directional cross-regulation of NK cell function during innate immune responses. , 2006, Transplant immunology.

[4]  K. Ishii,et al.  Innate immune recognition of, and regulation by, DNA. , 2006, Trends in immunology.

[5]  T. Ghosh,et al.  Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses. , 2006, Cellular immunology.

[6]  M. Herbst-Kralovetz,et al.  Toll-like receptors, innate immunity and HSV pathogenesis. , 2006, Herpes : the journal of the IHMF.

[7]  A. Krieg,et al.  Therapeutic potential of Toll-like receptor 9 activation , 2006, Nature Reviews Drug Discovery.

[8]  A. Ingham,et al.  Identification and expression of Toll-like receptors 1-10 in selected bovine and ovine tissues. , 2006, Veterinary immunology and immunopathology.

[9]  L. Babiuk,et al.  Bovine toll-like receptor 9: a comparative analysis of molecular structure, function and expression. , 2005, Veterinary immunology and immunopathology.

[10]  C. Gardiner,et al.  TLR7/8-Mediated Activation of Human NK Cells Results in Accessory Cell-Dependent IFN-γ Production1 , 2005, The Journal of Immunology.

[11]  K. Ishii,et al.  TLR ignores methylated RNA? , 2005, Immunity.

[12]  A. Moretta.  The dialogue between human natural killer cells and dendritic cells. , 2005, Current opinion in immunology.

[13]  L. Babiuk,et al.  Microarray analysis of gene expression following preparation of sterile intestinal “loops” in calves , 2005 .

[14]  M. Tomai,et al.  Synthetic TLR Agonists Reveal Functional Differences between Human TLR7 and TLR8 , 2005, The Journal of Immunology.

[15]  D. Golenbock,et al.  Mechanisms of TLR9 activation , 2004, Journal of endotoxin research.

[16]  A. Iwasaki,et al.  Toll-like receptor control of the adaptive immune responses , 2004, Nature Immunology.

[17]  J. Metzger,et al.  Toll‐like receptor 9 binds single‐stranded CpG‐DNA in a sequence‐ and pH‐dependent manner , 2004, European journal of immunology.

[18]  Qingsheng Li,et al.  Regulation of Dendritic Cell Function by NK Cells: Mechanisms Underlying the Synergism in the Combination Therapy of IL-12 and 4-1BB Activation1 , 2004, The Journal of Immunology.

[19]  Akiko Iwasaki,et al.  Recognition of single-stranded RNA viruses by Toll-like receptor 7. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Akira,et al.  Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.

[21]  Shizuo Akira,et al.  Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA , 2004, Science.

[22]  B. Monks,et al.  TLR9 signals after translocating from the ER to CpG DNA in the lysosome , 2004, Nature Immunology.

[23]  S. Akira,et al.  The Toll‐like receptor 7 (TLR7)‐specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily , 2003, European journal of immunology.

[24]  L. Babiuk,et al.  Safety and efficacy of CpG-containing oligodeoxynucleotides as immunological adjuvants in rabbits. , 2003, Vaccine.

[25]  L. Babiuk,et al.  Innate immune responses induced by CpG oligodeoxyribonucleotide stimulation of ovine blood mononuclear cells , 2003, Immunology.

[26]  J. Vieira,et al.  Local Delivery of CpG Oligodeoxynucleotides Induces Rapid Changes in the Genital Mucosa and Inhibits Replication, but Not Entry, of Herpes Simplex Virus Type 2 , 2003, Journal of Virology.

[27]  A. Furger,et al.  Bovine dendritic cells generated from monocytes and bone marrow progenitors regulate immunoglobulin production in peripheral blood B cells. , 2003, Comparative immunology, microbiology and infectious diseases.

[28]  G. Trinchieri,et al.  Interleukin-12 and the regulation of innate resistance and adaptive immunity , 2003, Nature Reviews Immunology.

[29]  L. Babiuk,et al.  Protection of Chickens against Escherichia coli Infections by DNA Containing CpG Motifs , 2003, Infection and Immunity.

[30]  P. Sopp,et al.  Development of detection methods for ruminant interleukin (IL)-12. , 2002, Journal of immunological methods.

[31]  T. Giese,et al.  Quantitative Expression of Toll-Like Receptor 1–10 mRNA in Cellular Subsets of Human Peripheral Blood Mononuclear Cells and Sensitivity to CpG Oligodeoxynucleotides1 , 2002, The Journal of Immunology.

[32]  S. Akira,et al.  Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway , 2002, Nature Immunology.

[33]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[34]  P. Cullis,et al.  On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids , 2001, Gene Therapy.

[35]  S. Hoffman,et al.  Interleukin-12- and Gamma Interferon-Dependent Protection against Malaria Conferred by CpG Oligodeoxynucleotide in Mice , 2001, Infection and Immunity.

[36]  N. Kadowaki,et al.  Distinct CpG DNA and Polyinosinic-Polycytidylic Acid Double-Stranded RNA, Respectively, Stimulate CD11c− Type 2 Dendritic Cell Precursors and CD11c+ Dendritic Cells to Produce Type I IFN1 , 2001, The Journal of Immunology.

[37]  M. Baca-Estrada,et al.  Induction of immune responses in newborn lambs following enteric immunization with a human adenovirus vaccine vector. , 2000, Vaccine.

[38]  S. Akira,et al.  A Toll-like receptor recognizes bacterial DNA , 2000, Nature.

[39]  R. Ulevitch,et al.  Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9. , 2000, European cytokine network.

[40]  M. Smith,et al.  Adjuvant activities of immune response modifier R-848: comparison with CpG ODN. , 2000, Cellular immunology.

[41]  G. Hartmann,et al.  CpG DNA and LPS induce distinct patterns of activation in human monocytes , 1999, Gene Therapy.

[42]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[43]  A. Krieg,et al.  Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA. , 1998, Journal of immunology.

[44]  H. Davis,et al.  CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice. , 1998, Journal of immunology.

[45]  A. Krieg,et al.  Cyclosporin A enhances IL-12 production by CpG motifs in bacterial DNA and synthetic oligodeoxynucleotides. , 1998, Journal of immunology.

[46]  J. Harty,et al.  CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. , 1998, Journal of immunology.

[47]  A. Krieg,et al.  CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species. , 1998, Journal of immunology.

[48]  K. Heeg,et al.  CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. , 1998, Journal of immunology.

[49]  A. Krieg,et al.  CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. , 1998, Journal of immunology.

[50]  C. Harding,et al.  CpG Oligodeoxynucleotides Act as Adjuvants that Switch on T Helper 1 (Th1) Immunity , 1997, The Journal of experimental medicine.

[51]  G. Trinchieri,et al.  Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-gamma). , 1997, Current opinion in immunology.

[52]  E. Unanue,et al.  Inter-relationship among macrophages, natural killer cells and neutrophils in early stages of Listeria resistance. , 1997, Current opinion in immunology.

[53]  C. Janeway,et al.  Innate immunity: impact on the adaptive immune response. , 1997, Current opinion in immunology.

[54]  E. Gilboa,et al.  Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo , 1996, The Journal of experimental medicine.

[55]  S. Beaucage,et al.  CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[56]  G. Bishop,et al.  CpG motifs in bacterial DNA trigger direct B-cell activation , 1995, Nature.

[57]  C. Hsieh,et al.  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. , 1993, Science.

[58]  R. Leventis,et al.  Interactions of cationic lipid vesicles with negatively charged phospholipid vesicles and biological membranes. , 1988, Biochemistry.

[59]  M. Chen,et al.  Efficacy of S26308 against guinea pig cytomegalovirus infection , 1988, Antimicrobial Agents and Chemotherapy.

[60]  Richard L. Miller,et al.  Administration of a dual toll-like receptor 7 and toll-like receptor 8 agonist protects against influenza in rats. , 2007, Antiviral research.

[61]  G. Trinchieri,et al.  Dendritic cell-NK cell cross-talk: regulation and physiopathology. , 2006, Current topics in microbiology and immunology.

[62]  L. Babiuk,et al.  Bovine and ovine blood mononuclear leukocytes differ markedly in innate immune responses induced by Class A and Class B CpG-oligodeoxynucleotide. , 2003, Oligonucleotides.

[63]  S. Akira,et al.  Toll-like receptors. , 2003, Annual review of immunology.

[64]  L. Babiuk,et al.  A slow release formulation for recombinant bovine interferon αI-1 , 1994 .

[65]  L. Babiuk,et al.  Capture immunoassay for ruminant tumor necrosis factor-α: comparison with bioassay , 1993 .

[66]  M. Kende,et al.  Treatment of Experimental Viral Infections with Immunomodulators , 1988 .